Literature DB >> 6213544

Subnormal pubertal increases of serum androgens in Turner's syndrome.

D Apter, H L Lenko, J Perheentupa, A Söderholm, R Vihko.   

Abstract

60 patients (139 blood specimens) with Turner's syndrome were investigated in order to obtain information concerning the origin of the increments of androgens during puberty. The concentrations of serum FSH, LH, estradiol, testosterone, 5 alpha-dihydrotestosterone, dehydroepiandrosterone, progesterone, 17-hydroxyprogesterone and pregnenolone in patients less than 10 years old were identical to those previously found in normal healthy girls of the same age. Hence, in adrenarche the early increase of androgen secretion is independent of gonadal hormone secretion. The later increases in serum testosterone and androstenedione in our patients were very small, and the age of 15 years, their concentrations were 50 and 60%, respectively, of the corresponding levels in normal girls of the same age. After 13 years of age, the mean serum dehydroepiandrosterone concentration was also slightly, but significantly (20-30%), lower than in normal girls of the same age. It is concluded that the ovaries are responsible for most of the pubertal rises in circulating testosterone and androstenedione, and possibly for a small part of the late pubertal rise in dehydroepiandrosterone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6213544     DOI: 10.1159/000179498

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  3 in total

Review 1.  Sex hormone replacement in Turner syndrome.

Authors:  Christian Trolle; Britta Hjerrild; Line Cleemann; Kristian H Mortensen; Claus H Gravholt
Journal:  Endocrine       Date:  2011-12-07       Impact factor: 3.633

2.  Sex differences in amygdala shape: Insights from Turner syndrome.

Authors:  Tamar Green; Kyle C Fierro; Mira M Raman; Lara Foland-Ross; David S Hong; Allan L Reiss
Journal:  Hum Brain Mapp       Date:  2016-01-28       Impact factor: 5.038

3.  Brain-Derived Neurotropic Factor, Vascular Endothelial Growth Factor and Matrix Metalloproteinases as Markers of Metabolic Status in Non-Growth Hormone-Treated Girls With Turner Syndrome.

Authors:  Ewa Błaszczyk; Jakub Gawlik; Joanna Gieburowska; Agnieszka Tokarska; Małgorzata Kimsa-Furdzik; Grzegorz Hibner; Tomasz Francuz; Aneta Monika Gawlik
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-27       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.